share_log

CORRESP: CORRESP

CORRESP: CORRESP

CORRESP:信函
美股SEC公告 ·  05/28 22:35

Moomoo AI 已提取核心信息

Apollomics Inc., a biopharmaceutical company, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form F-3. The company seeks to have the registration become effective on May 29, 2024, at 4:00 p.m. Eastern Time. This request was made in accordance with Rule 461 of Regulation C under the Securities Act of 1933. Apollomics has indicated that the effective date may be adjusted if necessary, based on further communication with the SEC. The company's legal counsel, Ryan Coombs from O'Melveny & Myers LLP, is the primary contact for this matter, with Yoon-jee Kim available in his absence.
Apollomics Inc., a biopharmaceutical company, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form F-3. The company seeks to have the registration become effective on May 29, 2024, at 4:00 p.m. Eastern Time. This request was made in accordance with Rule 461 of Regulation C under the Securities Act of 1933. Apollomics has indicated that the effective date may be adjusted if necessary, based on further communication with the SEC. The company's legal counsel, Ryan Coombs from O'Melveny & Myers LLP, is the primary contact for this matter, with Yoon-jee Kim available in his absence.
生物制药公司Apollomics Inc.正式请求美国证券交易委员会(SEC)加快其F-3表格注册声明的生效日期。该公司希望该注册生效日期设定为2024年5月29日,美国东部时间下午4:00。此请求是根据证券法规C下461号规则提出的。Apollomics表示,如果有必要,生效日期可能会根据与SEC的进一步沟通进行调整。该公司的法律顾问,O'Melveny & Myers LLP的Ryan Coombs是该事项的主要联系人,缺席时可联系Yoon-jee Kim。
生物制药公司Apollomics Inc.正式请求美国证券交易委员会(SEC)加快其F-3表格注册声明的生效日期。该公司希望该注册生效日期设定为2024年5月29日,美国东部时间下午4:00。此请求是根据证券法规C下461号规则提出的。Apollomics表示,如果有必要,生效日期可能会根据与SEC的进一步沟通进行调整。该公司的法律顾问,O'Melveny & Myers LLP的Ryan Coombs是该事项的主要联系人,缺席时可联系Yoon-jee Kim。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息